EpiPen Price Gouging is Old News

On Thursday, Mylan announced a series of steps that will make its EpiPen more affordable for some patients. Over the past few years, Mylan had raised a standard two-pack of EpiPens to roughly $600. It had cost $100 in 2009. Then, following a recent uproar, including a public tongue-lashing from Hillary Clinton and a US Senator […]

Read more "EpiPen Price Gouging is Old News"

Are you an Anti-Vaxxer?

Why do we question vaccines? And who are the thought leaders involved? Are they respectable, or are they hacks? And, more importantly, what can we glean from past debates about vaccines? In Elena Conis’s new book, we get a sense of this – and so much more. In the newest edition of Social History of […]

Read more "Are you an Anti-Vaxxer?"

In the Weeds: Understanding Government Action and Canada’s Marijuana Industry

What is happening with Canadian marijuana policy? We seem to be stuck in the weeds. And there’s a fog of confusion. According to Jim Bronskill, there are the 9 major factors that have driven the Canadian government’s “federal marijuana moves” over the past few months. The key source for him was a November 2015 ministerial briefing […]

Read more "In the Weeds: Understanding Government Action and Canada’s Marijuana Industry"

Mixed reviews for the Allard marijuana decision

Cannabis. Pot. Marijuana. Ganga. Weed. Grass. These are interesting times for sure. I was interviewed for the Saskatoon local news on the recent Allard decision. Honestly, I wasn’t terribly happy with this interview, but it can be viewed here. http://globalnews.ca/video/2541487/mixed-reviews-for-federal-court-marijuana-decision Finally: I would like to be upfront about something. The Global story used the word “Professor” […]

Read more "Mixed reviews for the Allard marijuana decision"